Pediatric Diabetes on the Rise: Trends in Incident Diabetes During COVID-19
PediatricsPage Navigation
A recent spike in cases of pediatric diabetes is observed and it has been assumed that there is a link between COVID pandemic and pediatric diabetes although the effects of the coronavirus disease pandemic on pediatric type 1 diabetes (T1D) and type 2 diabetes (T2D) are not clear.
OBJECTIVE
The research aimed to identify the trends in incidence of pediatric new-onset T1D and T2D during the COVID-19 pandemic.
METHODS
A retrospective chart review was conducted in the research and data such as demographics, anthropometrics, and initial laboratory results from patients with new-onset diabetes ages 0 through 21 years were recorded.
RESULTS
It was observed that the incidence of pediatric T1D increased to 48% during the pandemic. Incidence of pediatric T2D increased by 231% from 2019 to 2020 and the number of cases of pediatric T2D increased significantly more than pediatric T1D.
Further, patients with T2D were more likely to present in diabetic ketoacidosis (DKA) and mostly severe DKA was observed compared to moderate DKA in the incident cases of pediatric T2D. Moreover, during the pandemic incident cases of T2D accounted for more than one-half of all newly diagnosed pediatric diabetes cases (53%).
CONCLUSION
Conclusively, more number of pediatric T1D and T2D cases as well as an increase in DKA severity in T2D at presentation is observed during the COVID-19 pandemic. More importantly, incident T2D cases were higher than the incident T1D during the pandemic which suggests a disruption in the pediatric diabetes trends with profound health consequences.
Read more such content on Hidoc Dr | Medical Learning App for Doctors
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Q&A: Nipple-Sparing Mastectomy After Breast Radiation
2.
healthy despite having advanced cancer.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
5.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
1.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
2.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
3.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
4.
Blood Donation Sustainability Through Behavioral Science
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge